Nakao S - Search Results

1

Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes.

Suzuki T, Tomonaga M, Miyazaki Y, Nakao S, Ohyashiki K, Matsumura I, Kohgo Y, Niitsu Y, Kojima S, Ozawa K. Suzuki T, et al. Among authors: nakao s. Int J Hematol. 2008 Jul;88(1):30-35. doi: 10.1007/s12185-008-0119-y. Epub 2008 Jun 27. Int J Hematol. 2008. PMID: 18581199 Free PMC article. Review.

2

Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.

Chuhjo T, Yachie A, Kanegane H, Kimura H, Shiobara S, Nakao S. Chuhjo T, et al. Among authors: nakao s. Am J Hematol. 2003 Apr;72(4):255-8. doi: 10.1002/ajh.10303. Am J Hematol. 2003. PMID: 12666136 Free article.

3

Persistent remission after immunosuppressive therapy of hairy cell leukemia mimicking aplastic anemia: two case reports.

Sugimori C, Kaito K, Nakao S. Sugimori C, et al. Among authors: nakao s. Int J Hematol. 2003 May;77(4):391-4. doi: 10.1007/BF02982650. Int J Hematol. 2003. PMID: 12774930 Review.

4

Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical study.

Morishima Y, Ogura M, Nishimura M, Yazaki F, Bessho M, Mizoguchi H, Chiba S, Hirai H, Tauchi T, Urabe A, Takahashi M, Ohnishi K, Yokozawa T, Emi N, Hirano M, Shimazaki C, Nakao S, Kawai Y, Fujimoto M, Taguchi H, Jinnai I, Ohno R. Morishima Y, et al. Among authors: nakao s. Int J Hematol. 2004 Oct;80(3):261-6. doi: 10.1532/ijh97.04074. Int J Hematol. 2004. PMID: 15540902 Clinical Trial.

5

Isolated hyperkalemia associated with cyclosporine administration in allogeneic stem cell transplantation for renal cell carcinoma.

Takami A, Asakura H, Takamatsu H, Yamazaki H, Arahata M, Hayashi T, Shibayama M, Orito M, Yoshida T, Namiki M, Nakao S. Takami A, et al. Among authors: nakao s. Int J Hematol. 2005 Feb;81(2):159-61. doi: 10.1532/ijh97.04113. Int J Hematol. 2005. PMID: 15765786

6

Complete and durable remission of refractory mantle cell lymphoma with repeated rituximab monotherapy.

Ishiyama K, Takami A, Okumura H, Ozaki J, Shimadoi S, Yamanaka S, Nakao S. Ishiyama K, et al. Among authors: nakao s. Int J Hematol. 2005 May;81(4):319-22. doi: 10.1532/IJH97.04167. Int J Hematol. 2005. PMID: 15914363

7

Immune pathophysiology of aplastic anemia.

Nakao S, Feng X, Sugimori C. Nakao S, et al. Int J Hematol. 2005 Oct;82(3):196-200. doi: 10.1532/IJH97.05116. Int J Hematol. 2005. PMID: 16207590 Review.

8

Primary tracheal lymphoma: case report and literature review.

Takami A, Okumura H, Maeda Y, Kumano Y, Asakura H, Oda M, Omura K, Nakao S. Takami A, et al. Among authors: nakao s. Int J Hematol. 2005 Nov;82(4):338-42. doi: 10.1532/IJH97.05087. Int J Hematol. 2005. PMID: 16298827 Review.

9

Effects of sarpogrelate hydrochloride in a patient with chronic graft-versus-host disease: a case report.

Hayashi T, Morishita E, Ontachi Y, Yamazaki M, Asakura H, Yoshida T, Nakao S. Hayashi T, et al. Among authors: nakao s. Am J Hematol. 2006 Feb;81(2):121-3. doi: 10.1002/ajh.20511. Am J Hematol. 2006. PMID: 16432874 Free article.

10

Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease.

Takami A, Mochizuki K, Okumura H, Ito S, Suga Y, Yamazaki H, Yamazaki M, Kondo Y, Asakura H, Nakao S. Takami A, et al. Among authors: nakao s. Int J Hematol. 2006 Jan;83(1):80-5. doi: 10.1532/IJH97.05111. Int J Hematol. 2006. PMID: 16443558 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,684 results

Search Page

Filters